Single topical ivermectin head lice treatment very effective

Single topical ivermectin head lice treatment very effective
A single 10-minute, at-home treatment with topical ivermectin lotion eliminates head lice infestations in nearly all patients by the next day, according to a study published in the Nov. 1 issue of the New England Journal of Medicine.

(HealthDay)—A single 10-minute, at-home treatment with topical ivermectin lotion eliminates head lice infestations in nearly all patients by the next day, according to a study published in the Nov. 1 issue of the New England Journal of Medicine.

David M. Pariser, M.D., from the Eastern Virginia Medical School in Norfolk, and colleagues randomly assigned 765 patients with head lice (6 months of age or older) to a single application of 0.5 percent lotion or vehicle control without nit combing.

The researchers found that a significantly greater percentage of the ivermectin group was free of lice on day two (94.9 versus 31.3 percent), day eight (85.2 versus 20.8 percent), and day 15 (73.8 versus 17.6 percent). Both groups had similar frequency and severity of adverse events.

"In conclusion, ivermectin has a well-established safety profile, on the basis of extensive oral use, and a novel mode of action," Pariser and colleagues conclude. "Topical ivermectin showed high efficacy within 24 hours, with most treated patients remaining louse-free through the final assessment two weeks after a single treatment, without the need for nit combing."

The study was funded by Topaz Pharmaceuticals (now Sanofi Pasteur), which provided the study medication; two authors disclosed to Topaz Pharmaceuticals and .

More information: Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Head lice beginning to show permethrin resistance

Jun 05, 2012

(HealthDay) -- Although live head lice obtained from school-aged children in Paris remain susceptible to the insecticide malathion, approximately 14 percent have been found to be resistant to permethrin, suggesting ...

Sequential oral, topical tacrolimus benefits dermatitis

Sep 20, 2012

(HealthDay)—Sequential therapy with oral tacrolimus and topical tacrolimus may be an effective treatment for severe atopic dermatitis (AD), according to a pilot study published in the October issue of the ...

Recommended for you

Were clinical trial practices in East Germany questionable?

Oct 23, 2014

Clinical trials carried out in the former East Germany in the second half of the 20th century were not always with the full knowledge or understanding of participants with some questionable practices taking place, according ...

Schumacher's doctor sees progress after injury

Oct 23, 2014

A French physician who treated Michael Schumacher for nearly six months after the Formula One champion struck his head in a ski accident says he is no longer in a coma and predicted a possible recovery within three years.

User comments